can semaglutide cause celiac disease GLP-1s and Semaglutide and the Heart: Focus

Why individual responses vary so dramatically Two researchers can take identical doses of MOTS-c and experience completely different side effect profiles

A recent paper published in The Lancet showed that nearly 20% of participants in lifestyle interventions without medications gain weight, around 40% lose between 1-10% of their body weight, and just 13% lose more than 10%

START YOUR WEGOVY CONSULTATION Remember that your own first month results on Wegovy may differ from what was recorded in the trials

In some cases, switching to a different GLP-1 receptor agonist or alternative diabetes or weight management therapy may be recommended

Our clinicians stand ready to guide these discussions, ensuring patient safety and treatment efficacy